Αποτελέσματα Αναζήτησης
24 Οκτ 2024 · The following summarizes CDC's current age- and risk-based meningococcal vaccine recommendations by vaccine type. Access the official, full text of CDC's current and historical meningococcal vaccine recommendations.
26 Ιουν 2024 · CDC recommends meningococcal vaccination for adults at increased risk for meningococcal disease. Talk to a healthcare or vaccine provider about what is best for your specific situation.
First dose: 11 or 12 years of age. Second (booster) dose: 16 years of age. In addition to routine vaccination for adolescents, meningococcal ACWY vaccine is also recommended for certain groups of people: People at risk because of a serogroup A, C, W, or Y meningococcal disease outbreak. People with HIV.
MenACWY Recommendations. Administer MenACWY at age 11 or 12 years with a booster dose at 16 years of age. Administer 1 dose at age 13 through 15 years if not previously vaccinated. For persons vaccinated at age 13 through 15 years, administer a one-time booster dose, preferably at or after 16 through 18 years of age.
There are two kinds of meningococcal vaccines licensed by the Food and Drug Administration (FDA) for protection against serogroups A, C, W, and Y: meningococcal conjugate vaccine (MenACWY) and meningococcal polysaccharide vaccine (MPSV4).
Learning Objectives. Describe the Advisory Committee on Immunization Practices General Best Practice Guidelines on Immunization. Describe an emerging immunization issue. For each vaccine-preventable disease, identify those for whom routine immunization is recommended.
Routine Recommendations for Use of Meningococcal A,C,W,Y Vaccine (MenACWY) This table covers routine vaccination of preteens and teens, as well as catch-up vaccination of teens and young adults.
